Cancer drug shows potential as a treatment for muscular dystrophy

Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy. The researchers found that the drug — known as a colony-stimulating factor 1 receptor (CSF1R) inhibitor — helped slow the progression of Duchenne muscular dystrophy in mice by increasing the resilience of …

Cancer drug shows potential as a treatment for muscular dystrophy Read More »